


1. 4961-40-4
2. Triethylenetetramine Tetrahydrochloride
3. Triethylenetetramine, Tetrahydrochloride
4. 1,2-ethanediamine, N,n'-bis(2-aminoethyl)-, Tetrahydrochloride
5. 7360ure56q
6. N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;tetrahydrochloride
7. Trientine Tetrahydrochloride [usan]
8. N1,n1'-(ethane-1,2-diyl)bis(ethane-1,2-diamine) Tetrahydrochloride
9. 1,2-ethanediamine, N1,n2-bis(2-aminoethyl)-, Hydrochloride (1:4)
10. Mfcd00012890
11. N1,n1-(ethane-1,2-diyl)bis(ethane-1,2-diamine) Tetrahydrochloride
12. Nsc-158271
13. Triethylenetetraminetetrahydrochloride
14. Einecs 225-604-3
15. 3,6-diazaoctane-1,8-diamine Tetrahydrochloride
16. Nsc 158271
17. Unii-7360ure56q
18. Cuprior (tn)
19. Cuvrior
20. Teta 4hcl
21. N,n'-bis(2-aminoethyl)-1,2-ethanediamine Tetrahydrochloride
22. Dtxsid5063657
23. Triethylenetetramine Tetrahcl
24. Akos027320476
25. As-10237
26. Triethylenetetramine Tetrahydrochloride-d4
27. Db-051656
28. Ft-0635490
29. T1212
30. Trientine Tetrahydrochloride [who-dd]
31. Triethylenetetramine Tetrahydrochloride, 97%
32. D11649
33. 1,4,7,10-tetraazadecane Tetrahydrochloride
34. Q27266138
35. 2-ethanediamine,n,n'-bis(2-aminoethyl)-tetrahydrochloride
36. N1,n1'-(ethane-1,2-diyl)diethane-1,2-diamine Tetrahydrochloride
37. N1,n1-(ethane-1,2-diyl)bis(ethane-1,2-diamine)tetrahydrochloride
| Molecular Weight | 292.1 g/mol |
|---|---|
| Molecular Formula | C6H22Cl4N4 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 7 |
| Exact Mass | 292.056907 g/mol |
| Monoisotopic Mass | 290.059857 g/mol |
| Topological Polar Surface Area | 76.1 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 49.7 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 5 |
Cuprior is indicated for the treatment of Wilson's disease in adults, adolescents and children 5 years intolerant to D-penicillamine therapy.
A16AX